Clinical trial
Safety and Immunogenicity Study of an Inactivated H5N1 Influenza Vaccine (Whole…
NCT00349141 · Alachua Government Services, Inc., Industry · Completed
Key facts
| NCT number | NCT00349141 |
|---|---|
| Title | Safety and Immunogenicity Study of an Inactivated H5N1 Influenza Vaccine (Whole Virion, Vero Cell Derived) |
| Official title | A Phase I/II Dose Escalation Study of a Vero Cell-Derived, Whole Virus H5N1 Influenza Vaccine in Healthy Volunteers Aged 18 to 45 Years |
| Lead sponsor | Alachua Government Services, Inc., Industry |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Influenza |
| Intervention type | Biological |
| Interventions | Whole virion, Vero cell-derived influenza vaccine containing H5N1 HA antigen |
| Enrollment | 270 |
| Start date | Jun 1, 2006 |
| First posted | Jul 6, 2006 |
| Last update posted | Oct 9, 2015 |
| Countries | Austria, Singapore |
At a glance
- 1–9 Study sites
- No Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: